Investment Type: Venture Capital
Mentions in press and media 2
| Date | Title | Description |
| 11.03.2009 | Heart drug co. Relypsa gets $10M more to complete trials | Pharmaceutical company Relypsa announced that its investors extended its first round of funding by $10 million to a total $43 million to help it finish phase-two clinical trials on its lead drug candidate, a treatment that could alleviate s... |
| 05.10.2007 | TetraPhase Aims to Fill the Antibiotic Pipeline—and its Executive Office | Share Share on Facebook Share on Twitter LinkedIn Email Reprints TetraPhase Pharmaceuticals, spun out of Harvard in 2006 with $25 million to develop synthetic antibiotics, reached an important corporate milestone last week: the company had ... |